Targeting SUMO2 reverses aberrant epigenetic rewiring driven by SS18::SSX fusion oncoproteins and impairs

Rema Iyer1, Anagha Deshpande1, Aditi Pedgaonkar1

  • 1Cancer Genome and Epigenetics Program, National Cancer Institute-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.

The EMBO Journal
|August 13, 2025
PubMed

Insights

Researchers identified small ubiquitin-like modifier 2 (SUMO2) as a key dependency in synovial sarcoma (SySa). Inhibiting SUMO2 effectively targets SySa cells, offering a promising new therapeutic strategy for this aggressive cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Synovial sarcoma (SySa) is an aggressive soft tissue cancer driven by the SS18::SSX fusion protein.
  • There is a critical need for targeted therapies against SySa.

Purpose of the Study:

  • To identify genes selectively essential for SySa cell fitness.
  • To explore the therapeutic potential of targeting identified vulnerabilities.

Main Methods:

  • Mined Cancer Dependency Map data for SySa-selective genes.
  • Performed targeted CRISPR library screening.
  • Utilized SUMO2 inhibition with TAK-981.
  • Conducted transcriptomic profiling and epigenetic analysis.

Main Results:

  • Small ubiquitin-like modifier 2 (SUMO2) was identified as a critical dependency in SySa.
  • SUMO2 inhibition potently suppressed SySa cell growth in vitro and in vivo.
  • SUMO2 inhibition reversed the SS18::SSX-driven gene expression program.
  • Targeting SUMO2 reduced SS18::SSX protein levels and H2AK119ub epigenetic marks.

Conclusions:

  • SUMO2 is a novel and selective vulnerability in synovial sarcoma.
  • Targeting SUMO2 presents a promising therapeutic strategy for soft tissue tumors.

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K